The short answer
Prejuvenation — a portmanteau of "prevention" and "rejuvenation" — refers to starting aesthetic treatments before visible signs of aging appear, rather than correcting them after they develop. The concept has surged in popularity among patients in their 20s and early 30s, driven by social media visibility and a generational shift toward proactive maintenance.
The core idea is biologically plausible: collagen production begins declining by approximately 1% per year after age 25, and repetitive facial muscle activity creates dynamic wrinkles that eventually become static lines. Reducing that activity early and supporting collagen production before significant loss occurs may delay the onset of visible aging.
But "plausible" is not the same as "proven by high-quality longitudinal trials." The evidence supports specific elements of prejuvenation — particularly preventative neuromodulator use — while other elements remain more marketing than mechanism.
What prejuvenation actually includes
Prejuvenation is not a single treatment. It is a treatment philosophy that may include:
- Preventative neuromodulators (Botox, Dysport, Xeomin, Jeuveau) at low doses to reduce repetitive muscle contractions before static lines form
- Collagen-stimulating treatments (microneedling, fractional lasers, biostimulators) to support dermal collagen production during the window when it is still relatively robust
- Medical-grade skincare — retinoids, antioxidants, sunscreen — to protect against extrinsic aging from UV and environmental damage
- Energy-based device maintenance — gentle resurfacing (Clear + Brilliant, Moxi) to improve skin texture and tone without significant downtime
The common thread: intervene early with low-intensity treatments to reduce the cumulative damage that eventually requires higher-intensity correction.
The evidence for preventative Botox
The twin study
The most frequently cited evidence for preventative botulinum toxin comes from a 2006 study published in Archives of Facial Plastic Surgery comparing identical twins over 13 years. One twin received regular botulinum toxin type A treatments in the forehead and glabellar region; the other received minimal or no treatment.
The treated twin showed notably fewer imprinted forehead and glabellar lines — wrinkles visible even at rest — and less noticeable crow's feet when smiling. Untreated facial areas (such as nasolabial folds) aged comparably in both twins, suggesting that the difference was specific to the treated muscles rather than a general aging effect.
This was an observational study with a sample size of two. It supports the biological plausibility of prevention but does not constitute a controlled trial.
Systematic review evidence
A 2025 systematic review published on PubMed Central evaluated the preventive role of botulinum toxin in facial aging. The review found that early BoNT application may reduce muscle hyperactivity, delay the formation of dynamic wrinkles, and minimize the development of static lines over time. Histological studies suggest a potential remodeling effect on dermal collagen.
However, the authors noted that "data remain heterogeneous, and long-term safety and efficacy outcomes are not yet fully established." They concluded that further longitudinal, high-quality studies are needed to substantiate the role of preventive BoNT within evidence-based aesthetic protocols.
The 2022 evidence-based review
A 2022 review in the Journal of Cosmetic Dermatology examined botulinum toxin use specifically in young adults (millennials). The authors reviewed randomized controlled trials and surveyed 141 aesthetic practitioners across multiple countries. They found that wrinkle prevention was the number one reason younger patients sought treatment, and clinical data supported Botox's efficacy for both treatment and prevention in younger adults. The researchers recommended an individualized approach with lower doses for younger patients.
What the evidence does not prove
No large-scale, long-term, placebo-controlled randomized trial has proven that starting Botox at 25 prevents more wrinkles over a lifetime than starting at 40. The biological mechanism is sound — less muscle contraction means less repetitive skin folding — but the magnitude and consistency of the preventive benefit across diverse populations and ages remains uncertain.
Preventative Botox also cannot prevent:
- Wrinkles caused by sun damage (collagen breakdown from UV exposure)
- Volume loss from fat and bone density changes
- Skin laxity from structural aging and gravity
- Genetic aging patterns unrelated to muscle activity
It addresses one specific mechanism of aging: dynamic wrinkles formed by repetitive muscle movement.
Collagen banking: the skin savings account
"Collagen banking" extends prejuvenation beyond neuromodulators. The idea: build as much collagen as possible while production is still relatively robust (20s and early 30s), so that when the decline accelerates, you start from a higher baseline.
Treatments used for collagen banking
| Treatment | Mechanism | Evidence strength | Typical cost per session |
|---|---|---|---|
| Microneedling | Mechanical stimulation of fibroblasts | Moderate — multiple RCTs show collagen induction | $200–$700 |
| Fractional non-ablative lasers (Clear + Brilliant, Moxi) | Thermal injury triggers collagen remodeling | Moderate — clinical studies show improved texture and tone | $300–$750 |
| Biostimulators (Sculptra, Radiesse) | PLLA or CaHA particles stimulate collagen over months | Strong — FDA-cleared with clinical trial data | $700–$1,500 |
| RF microneedling (Morpheus8, Sylfirm X) | Radiofrequency energy + mechanical needling | Moderate — growing evidence for collagen stimulation | $500–$1,500 |
| Retinoids (tretinoin, adapalene) | Increase cell turnover, stimulate collagen synthesis | Strong — decades of evidence | $20–$200/month |
A study published in Plastic and Reconstructive Surgery found that combining biostimulatory fillers with RF microneedling improved collagen density by approximately 25% over six months.
What collagen banking realistically delivers
These treatments can measurably improve skin thickness, elasticity, and texture. What they cannot do is permanently halt collagen decline. The body's aging processes continue regardless of treatment. Collagen banking is maintenance, not a cure — it shifts the starting line, not the trajectory.
When to start: the age question
There is no single correct age to begin prejuvenation. Most board-certified dermatologists and plastic surgeons recommend considering treatment based on visible signs rather than a chronological threshold:
- Late 20s to early 30s: Appropriate for patients who begin noticing faint lines during facial expression that disappear at rest. This is the window where preventative neuromodulators have the most theoretical benefit — before dynamic lines become static.
- Mid-20s: Reasonable for patients with very expressive facial muscles who already show visible creasing during animation, or those with strong family history of early wrinkling. Starting too early risks treating a problem that may never develop to a degree that bothers the patient.
- Before any visible lines: Not universally recommended. The American Academy of Dermatology notes that neuromodulator treatment should address a clinical need. Injecting patients with no visible dynamic lines is a commercial decision, not a clinical one.
The appropriate timing depends on genetics, sun exposure history, skin type, muscle activity patterns, and — critically — whether the patient actually wants treatment.
Cost considerations
Prejuvenation is an ongoing financial commitment. Unlike corrective treatment (which addresses an existing problem in a defined number of sessions), preventative treatment is continuous by design.
Annual cost estimates
| Treatment | Frequency | Annual cost range |
|---|---|---|
| Preventative Botox (low dose, 3 areas) | Every 3–4 months | $600–$2,400/year |
| Microneedling | 2–3 sessions/year | $400–$2,100/year |
| Medical-grade skincare (retinoid, vitamin C, sunscreen) | Daily | $240–$1,200/year |
| Fractional laser maintenance (Moxi or Clear + Brilliant) | 1–2 sessions/year | $300–$1,500/year |
A comprehensive prejuvenation program can cost $1,500–$7,000 per year. For context, a single deep-plane facelift (the surgical intervention prejuvenation aims to delay) costs $15,000–$30,000. Whether the cumulative cost of years of preventative treatment represents a financial advantage depends on how long the delay lasts — which is exactly what the evidence cannot yet quantify.
Who should not pursue prejuvenation
- Patients under 18. No neuromodulator is FDA-approved for cosmetic use in minors. Facial anatomy is still developing.
- Pregnant or breastfeeding patients. No botulinum toxin product is approved for use during pregnancy or lactation.
- Patients with body dysmorphic tendencies. Prejuvenation requires ongoing treatment and attention to subtle facial changes. For patients predisposed to excessive concern about appearance, the cycle may worsen rather than improve well-being.
- Patients expecting to "stop aging." Prejuvenation slows one mechanism of aging. It does not stop aging, and providers who suggest otherwise are misrepresenting the evidence.
What to ask before starting
- What specific aging concern am I addressing? If you cannot name the line, fold, or texture change that bothers you, you may not need treatment yet.
- What is the evidence that early treatment will change my outcome long-term? A good provider will be honest about the limits of the data.
- How much will this cost per year, and for how many years? Prejuvenation is not a one-time expense.
- What happens if I stop? With neuromodulators, muscle activity gradually returns to baseline. With collagen-stimulating treatments, the aging process resumes at its natural rate. Stopping does not cause accelerated aging — a common misconception.
- What is the lowest effective dose for my anatomy? For preventative neuromodulation, less is generally more. Ask the provider to justify the recommended unit count against your actual muscle activity.
Sources
- Kadunc BV, Trindade de Almeida AR. Long-term effects of botulinum toxin type A (Botox) on facial lines: a comparison in identical twins. Arch Facial Plast Surg. 2006;8(6):426-431. doi:10.1001/archfaci.8.6.426
- Proactive Aesthetic Strategies: Evaluating the Preventive Role of Botulinum Toxin in Facial Aging. PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12372128
- Foo TH, et al. Botulinum toxin for cosmetic treatments in young adults: An evidence-based review and survey on current practice among aesthetic practitioners. J Cosmet Dermatol. 2022. https://pubmed.ncbi.nlm.nih.gov/36445847
- Prejuvenation: The Global New Anti-Aging Trend. PMC. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10339083
- FDA. BOTOX Cosmetic (onabotulinumtoxinA) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103000s5316s5319s5323s5326s5331lbl.pdf
- American Academy of Dermatology. Botulinum Toxin: What to Expect. https://www.aad.org/public/cosmetic-skin/botox
- American Society of Plastic Surgeons. Botulinum Toxin Average Cost. https://www.plasticsurgery.org/cosmetic-procedures/botulinum-toxin
